| ATCC 49686| Clostridium oxalicum| Clostridium oxalicum Dehning and Schink 1990| DSM 5503| Oxalophagus oxalicus| Oxalophagus oxalicus (Dehning and Schink 1990) Collins et al. 1994| strain Alt Ox1
Role in Oxalate Metabolism: Oxalophagus oxalicus is capable of degrading oxalate, a compound found in foods such as spinach, rhubarb, and certain nuts. Oxalate metabolism by Oxalophagus oxalicus may contribute to the reduction of oxalate levels in the gut, potentially reducing the risk of kidney stones and other oxalate-related disorders.
Beneficial Effects: Reduction of oxalate levels in the gut through the action of Oxalophagus oxalicus may have beneficial effects on host health, particularly for individuals prone to kidney stone formation or hyperoxaluria. By breaking down oxalate, Oxalophagus oxalicus may help prevent the formation of calcium oxalate crystals, which are a common component of kidney stones.
Potential Applications: Oxalophagus oxalicus and other oxalate-degrading bacteria have been investigated for their potential therapeutic applications in the prevention and treatment of kidney stones and other oxalate-related disorders. Strategies aimed at promoting the growth of oxalate-degrading bacteria in the gut, such as dietary interventions or probiotic supplementation, are areas of ongoing research.
Safety Considerations: While Oxalophagus oxalicus and other oxalate-degrading bacteria are generally considered safe, their use as probiotics or therapeutic agents requires further research to ensure efficacy and safety. Additionally, interactions between Oxalophagus oxalicus and the gut microbiota, as well as potential effects on host physiology, need to be thoroughly investigated.
Oxalophagus oxalicus impacts on other bacteria of the same rank
Other bacteria of the same rank impacting Oxalophagus oxalicus
This is an Academic site. It generates
theoretical models
of what may benefit a specific microbiome results.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some
hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription
All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]